| (19) |
 |
|
(11) |
EP 2 749 280 A3 |
| (12) |
EUROPEAN PATENT APPLICATION |
| (88) |
Date of publication A3: |
|
20.08.2014 Bulletin 2014/34 |
| (43) |
Date of publication A2: |
|
02.07.2014 Bulletin 2014/27 |
| (22) |
Date of filing: 17.02.2012 |
|
| (51) |
International Patent Classification (IPC):
|
|
| (84) |
Designated Contracting States: |
|
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL
NO PL PT RO RS SE SI SK SM TR |
| (30) |
Priority: |
17.02.2011 IN MM04462011
11.03.2011 IN MM06942011
28.03.2011 IN MM09532011
19.05.2011 IN MM15352011
19.05.2011 IN MM15342011
31.05.2011 IN MM16132011
07.07.2011 IN MM19652011
07.07.2011 IN MM19662011
|
| (62) |
Application number of the earlier application in accordance with Art. 76 EPC: |
|
12707369.0 / 2675439 |
| (71) |
Applicant: Cipla Limited |
|
Mumbai - 400 008 (IN) |
|
| (72) |
Inventors: |
|
- Malhotra, Geena
400 010 Mumbai (IN)
- Purandare, Shrinivas Madhukar
400 031 Mumbai (IN)
|
| (74) |
Representative: King, Lawrence |
|
A.A. Thornton & Co.
10 Old Bailey
London EC4M 7NG
London EC4M 7NG (GB) |
|
| |
|
| (54) |
Combination of glycopyrronium and formoterol |
(57) The present invention relates to pharmaceutical compositions for inhalation comprising
glycopyrronium in combination with formoterol and fluticasone; to a process for preparing
such compositions and to the use of such compositions for the prevention and/or treatment
of respiratory, inflammatory or obstructive airway disease.